Onivyde (nanoliposomal irinotecan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Onivyde (nanoliposomal irinotecan), covering 2024-11-01 to 2024-11-01. Get the full timeline:
Most recent: Clinical Trial Update: NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer [Phase 2]